Other examples of early targets for molecular imaging approaches in CRC include carcinoembyonic antigen (CEA), cyclooxygenase 2 (PTGS2), Thomsen-Friedenreich antigen and others (21–25). The gene discussed is PTGS2; the disease is colorectal carcinoma.